Journal of the American College of Cardiology
Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes.
The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure.
Effect of serelaxin on mode of death in acute heart failure: results from the RELAX-AHF study.
Reply: Mode of Death Prevention by Serelaxin.
Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: The ATOMIC-AHF Study.
Influence of Sacubitril/Valsartan (LCZ696) on 30-Day Readmission After Heart Failure Hospitalization.
Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial.
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.
Cardiac Calcitropes, Myotropes, and Mitotropes: JACC Review Topic of the Week.
Conduct of Clinical Trials in the Era of COVID-19: JACC Scientific Expert Panel.
